Pediatric ID News

A study found no reported serious adverse events among children who received a COVID-19 vaccine after recovering from multisystem inflammatory syndrome in children, or MIS-C, according to results published in JAMA Network Open.

Updated COVID-19 shots, including bivalent boosters, dominated vaccine news in 2022, but good news also came for vaccines against malaria, Ebola and cancer.

In 2022, the front page of Infectious Disease News mostly peered beyond COVID-19 to showcase triumphs and progress being made elsewhere in the field of infectious disease.

There was plenty of FDA news this year not related to COVID-19.

As the COVID-19 pandemic enters its 4th year, its effect on children continues to be widely studied. We compiled a list of pediatric COVID-19 stories reported over the course of the past year.

We continue to be captivated by the stories you tell in our “Hooked on ID” series.

Protection against the omicron variant from the Pfizer-BioNTech COVID-19 vaccine waned after 3 months in children aged 5 to 11 years but was restored by a booster shot, according to study findings published in JAMA Network Open.

I got into the medical field to solve problems, and the field of infectious diseases exemplifies that.

Q&As are a good opportunity for experts to communicate directly with readers about emerging topics in medicine. Below is a list of Q&As related to pediatrics that were published in 2022.

At the end of this month, Anthony S. Fauci, MD, will officially step down as director of the National Institute of Allergy and Infectious Diseases, which he has led for nearly 4 decades.